According to filings with the U.S. Securities and Exchange Commission, Prosper Health is raising up to $16,234,237.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Prosper Health
Prosper Health provides affordable and accessible therapy to autistic adults. Our therapy is neurodivergent affirming, covered by commercial insurance, and available via telehealth in multiple states. We are a startup on a mission to help autistic adults live happier and healthier lives.

To learn more about Prosper Health, visit http://www.prosperhealth.io/
Prosper Health Linkedin Page: https://www.linkedin.com/company/prosper-autism/

Contact:
Ben Schecter, Chief Executive Officer
954-366-9978
https://www.linkedin.com/in/ben-schecter-650292b3/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.